Join the Campaign

Experimental drug promises to kill the influenza virus in a day

A Japanese company reports that it has developed a drug that can kill the influenza virus within 1 day. However, even if the drug proves successful, it likely will not be available in the United States until 2019 at the earliest.

A Japanese company reports that it has developed a drug that can kill the influenza virus within 1 day. However, even if the drug proves successful, it likely will not be available in the United States until 2019 at the earliest. According to the company, a late-stage trial involving Japanese and American influenza patients found that for people who took the experimental Shionogi compound, the median time to eliminate the virus was 24 hours. That is much faster than other influenza drugs on the market, and it only requires one dose. Both the experimental compound and oseltamivir phosphate (Tamiflu—Roche), which requires two doses a day for 5 days, take approximately the same amount of time to entirely contain symptoms of influenza; however, Shionogi claims that its compound offered immediate relief more quickly. Shionogi and Roche, which has acquired the international license to distribute Shionogi's experimental drug, are in the final stages of conducting a second late-stage global trial. Other companies are testing new compounds to test influenza A; but Shionogi's is furthest along.

Ad Position: 
Bottom Center Aligned
Article URL: 
https://www.wsj.com/articles/experimental-drug-promises-to-kill-the-flu-virus-in-a-day-1518264004?mod=ITP_businessandfinance_2&tesla=y
  • Join the Campaign
  • Take Action ALT Text
  • Get the facts ALT text
LATEST NEWS
October 17, 2017
October 17, 2017
APhA Executive Vice President and CEO Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA, testified in a hearing about drug prices held by the...
Gag clauses, lack of provider status hinder cost-effective care, importation is no solution, APhA CEO says
MORE
August 14, 2017
August 14, 2017
Tennessee saw major provider status legislation take effect on July 1. “Pharmacists as Providers” (HB 405/SB 461) gives Tennessee pharmacists formal...
‘Pharmacists as providers’ legislation went into effect July 1
MORE
July 13, 2017
July 13, 2017
The Massachusetts Senate and House of Representatives health care committee held a hearing on legislation that would expand the scope of practice...
Hearing held last month included testimony from pharmacists and physicians
MORE
Advertisement